Cardiovascular haemodynamics during fluroxene anaesthesia in patients with aortic valvular disease.
D000328:Adult; D000769:Anesthesia, Inhalation; D001021:Aortic Valve / Q000601:surgery*; D001794:Blood Pressure / Q000187:drug effects*; D001810:Blood Volume / Q000187:drug effects*; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects*; D002306:Cardiac Volume / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004987:Ethers / Q000494:pharmacology*; D005260:Female; D005703:Gallamine Triethiodide; D006339:Heart Rate / Q000187:drug effects*; D006349:Heart Valve Diseases / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011229:Preanesthetic Medication; D011674:Pulse / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects*
D004987:Ethers; D002245:Carbon Dioxide; D005703:Gallamine Triethiodide; D010100:Oxygen